Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Fixed Dose Combination of DW340 in Patients With Acute Low Back Pain [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of a fixed-dose combination (DW340) in patients with acute low back pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low Back Pain

Drugs mentioned

• DW340

Snippet

Sponsor: Daewon Pharmaceutical Co., Ltd. | Conditions: Acute Low Back Pain | Phase 2 | Status: COMPLETED